CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Cash and Short Term Investments (Quarterly): 394.26M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 394.26M |
| September 30, 2023 | 438.78M |
| June 30, 2023 | 213.84M |
| March 31, 2023 | 236.36M |
| December 31, 2022 | 135.48M |
| September 30, 2022 | 153.42M |
| June 30, 2022 | 163.88M |
| March 31, 2022 | 188.56M |
| December 31, 2021 | 186.54M |
| September 30, 2021 | 113.79M |
| June 30, 2021 | 106.13M |
| March 31, 2021 | 125.46M |
| December 31, 2020 | 146.32M |
| September 30, 2020 | 161.26M |
| June 30, 2020 | 168.91M |
| March 31, 2020 | 176.23M |
| December 31, 2019 | 190.94M |
| September 30, 2019 | 218.59M |
| June 30, 2019 | 241.21M |
| March 31, 2019 | 264.76M |
| December 31, 2018 | 178.66M |
| Date | Value |
|---|---|
| September 30, 2018 | 198.14M |
| June 30, 2018 | 212.08M |
| March 31, 2018 | 229.54M |
| December 31, 2017 | 97.21M |
| September 30, 2017 | 102.17M |
| June 30, 2017 | 16.73M |
| March 31, 2017 | 23.40M |
| December 31, 2016 | 16.99M |
| September 30, 2016 | 23.13M |
| June 30, 2016 | 29.12M |
| March 31, 2016 | 35.25M |
| December 31, 2015 | 41.48M |
| September 30, 2015 | 46.85M |
| June 30, 2015 | 27.03M |
| March 31, 2015 | 32.79M |
| December 31, 2014 | 34.80M |
| September 30, 2014 | 42.63M |
| June 30, 2014 | 23.63M |
| March 31, 2014 | 28.53M |
| December 31, 2013 | 31.24M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
106.13M
Minimum
Jun 2021
438.78M
Maximum
Sep 2023
197.89M
Average
176.23M
Median
Mar 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences Inc | 4.718B |
| Assure Holdings Corp | 0.123M |
| Societal CDMO Inc (DELISTED) | 8.095M |
| AN2 Therapeutics Inc | 114.21M |
| Madrigal Pharmaceuticals Inc | 1.059B |